Americus Has Reverse Stock Split

Irvine-based Americus Funding Corp. said Tuesday that it will impose a 1 for 200 reverse split of its outstanding shares of common stock, effective June 15.

The action will reduce the company’s outstanding shares of common stock to about 2.8 million.

The company also will reduce the authorized shares of common stock to 10 million. Americus is the parent of Advanced Immunotherapeutics Inc., which is developing drugs to treat various neurological and immunological diseases.